TruGenomix Health and Unite Genomics has chosen five start-ups for its eighth class. The new cohort are focused on skin microbial therapeutics, fertility science, chronic disease alleviation, post-traumatic stress disorder treatment, biopharmaceutical services and clinical research services. The start-ups – Illumina , MedAnswers , Mediphage Bioceuticals, Helix – will gain access to advice and expertise in business and financing. Companies selected for Illumina’s seed investment program, receive backing fro accredited investor through a convertible note and dollar-for-dollar matching funding through the company’s $40 million Illumina Accelerator Boost Capital, (if they raise between $1 million and $5 million of qualifying capital). The companies will also gain access to Illumina spin-out TruGenomix Health and Unite Genomics and its experts in bioinformatics, applied genomics, product development and consumer marketing.
TruGenomix Health and Unite Genomics has chosen five start-ups for its eighth class. The new cohort are focused on skin microbial therapeutics, fertility science, chronic disease alleviation, post-traumatic stress disorder treatment, biopharmaceutical services and clinical research services. The start-ups – Illumina , MedAnswers , Mediphage Bioceuticals, Helix – will gain access to advice and expertise in business and financing. The companies will also gain access to Illumina spin-out TruGenomix Health and Unite Genomics and its experts in bioinformatics, applied genomics, product development and consumer marketing.